Tilray Brands Inc is a global leader in the cannabis industry, specializing in the cultivation, production, and distribution of a diverse range of cannabis products
The company operates across various segments, including medical and recreational cannabis, as well as hemp-derived wellness products. Tilray focuses on innovation and quality, offering a portfolio that encompasses various formats such as dried flower, oils, edibles, and beverages. In addition to its core cannabis business, Tilray is dedicated to advancing research, education, and consumer awareness within the rapidly evolving market, positioning itself as a key player in the development and expansion of cannabis-related offerings worldwide.
Tilray Brands stock is trading lower on Monday, alongside other cannabis-related stocks, following President Donald Trump's announcement of new tariffs on imported goods from Canada, Mexico and China, set to take effect Tuesday.
Group behind failed attempt to legalize recreational cannabis in FL has launched new initiative for 2026 ballot. Allows adult use with limits and restrictions.
Shares of cannabis company Tilray Brands (NASDAQTLRY)
fell 13.5% in the morning session after the company reported underwhelming fourth quarter results. Its revenue and EBITDA missed significantly, and its gross margin fell short of Wall Street's estimates. Also, the company recorded significant operating losses and continued to burn cash. On the other hand, revenue guidance for 2025 came in ahead of expectations, though sales are partly benefiting from recent acquisitions following the company's expansion to the beverage market, which suggests organic growth is not as strong. Zooming out, we think this was a mixed quarter. The market seemed to focus on the negatives, and the stock traded down.
